ABE8EY149V
ABE8EY149V has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Feb 6, 2026: “Therapeutic adenine base editor with minimized off-target effects”.
1 paper studies it1 findingUpdated
See all 1 papers on ABE8EY149V
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
Mice: a single group. Cells, worms or flies and humans: nothing yet.
- 1 lab in 1 country
- Funders: Agricultural Science and Technology Innovation Program and 3 more
- Animals1
What did studies of ABE8EY149V find?
1Studies of ABE8EY149V measured one outcome, mortality.
Mortality
downin mice1
1 study
Mortality
downin mice1
ABE8EY149V prevents mortality in hereditary tyrosinemia type I mice.
“ABE8eY149V editing of hydroxyphenylpyruvate dioxygenase (Hpd) gene prevented lethality in hereditary tyrosinemia type I mice.”
Animalsin hereditary tyrosinemia type I mice
Therapeutic adenine base editor with minimized off-target effects
Protein & cell
Latest
1 paper in 12 monthsProtein & Cell
Therapeutic adenine base editor with minimized off-target effects
Experiments in miceInterventions